Long-term incidence of death due to thromboembolic disease among patients with unprovoked pulmonary embolism

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 5, 2009, Pages 418-424

  White, Richard H ^a,b   Murin, Susan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Emergency Medicine   (United States)

Author keywords

Chronic thromboembolic pulmonary hypertension; Death; Epidemiology; Pulmonary embolism; Venous thromboembolism

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOTTING DISORDER; COMORBIDITY; DEEP VEIN THROMBOSIS; HUMAN; INCIDENCE; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; MORTALITY; PULMONARY HYPERTENSION; RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SUDDEN DEATH; VENOUS THROMBOEMBOLISM;

CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; PULMONARY EMBOLISM; RISK FACTORS; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTORS; WORLD HEALTH;

EID: 68949192571     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832d044a     Document Type: Review

References (32)

1. Goldhaber SZ. Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro. Arch Intern Med 2005; 165:2197-2199; discussion 2204-2205.
2. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008; 133:454S-545S. (Pubitemid 351892971)
3. Agnelli G, Becattini C, Prandoni P. Recurrent venous thromboembolism in men and women. N Engl J Med 2004; 351:2015-2018.
4. Eriksson H, Lundstrom T, Wahlander K, et al. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran. Thromb Haemost 2005; 94:522-527.
5. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160:761-768.
6. Keeling D. Duration of anticoagulation: decision making based on absolute risk. Blood Rev 2006; 20:173-178.
7. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 2007; 92:199-205.
8. Murin S, Romano PS, White RH. Comparison of outcomes after hospitaliza-tion for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88:407-414.
9. Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. Proc Am Thorac Soc 2006; 3:564-567. (Pubitemid 44411620)
10. Kahn SR. The postthrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis 2006; 21:41-48.
11. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348:423-428.
12. Kearon C. Long-term management of patients after venous thromboembolism. Circulation 2004; 110:I10-18.
13. Kyrle PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350:2558-2563.
14. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 2007; 13:377-383.
15. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93:298-305.
16. Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 1 79:41 7-426.
17. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355:1780-1789.
18. Keenan CR, Murin S, White RH. High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses. J Thromb Haemost 2007; 5:1185-1190.
19. Tavora F, Crowder C, Kutys R, et al. Discrepancies in initial death certificate diagnoses in sudden unexpected out-of-hospital deaths: the role of cardiovascular autopsy. Cardiovasc Pathol 2008; 17:178-182.
20. Lucena J, Rico A, Vazquez R, et al. Pulmonary embolism and sudden- unexpected death: prospective study on 2477 forensic autopsies performed at the Institute of Legal Medicine in Seville. J Forensic Leg Med 2009; 16:196-201.
21. Douketis JD, Gu CS, Schulman S, etal. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147:766-774.
22. White RH, Zhou H, Murin S. Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost 2008; 99:683-690.
23. Buller HR, Cohen AT, Davidson B, et al. Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med 2007; 357:1105-1112.
24. PengoV, Lensing AWA, Prins MH, etal. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350:2257-2264.
25. Agnelli G, Prandoni P, Becattini C, etal. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139:19-25.
26. Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85:253-262.
27. Peacock A, Simonneau G, Rubin L Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006; 3:608-614. (Pubitemid 44411628)
28. Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest 2006; 130:172-175.
29. Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 1999; 99:1325-1330.
30. de Perrot M, Fadel E, McRae K, et al. Evaluation of persistent pulmonary hypertension after acute pulmonary embolism. Chest 2007; 132:780-785.
31. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003; 90:372-376.
32. Suntharalingam J, Goldsmith K, van Marion V, et al. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008; 31:736-741.